Inactive Instrument

Eagle Health Holdings Limited

Equities

EHH

AU000000EHH5

Eagle Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019

February 28, 2020 at 03:23 am EST

Eagle Health Holdings Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was AUD 103.202 million compared to AUD 111.014 million a year ago. Net income was AUD 8.510 million compared to AUD 18.735 million a year ago.

Latest news about Eagle Health Holdings Limited

Eagle Health Holdings Limited Announces Board Changes	20-09-02	CI
Eagle Health Holdings Limited Announces Management Changes	20-08-31	CI
Eagle Health Holdings Limited Announces Resignation of Gang Xu as Managing Director	20-06-15	CI
Eagle Health Holdings Limited Withdraws Final Dividend for the Year Ended December 31, 2019	20-04-14	CI
Eagle Health Holdings Limited Informs Delay Financial Statements for the Year Ending 31 December 2019	20-03-31	CI
Eagle Expands Manufacturing Facilities for Medical Masks; Secures First Purchase Order for its Disposable Medical Masks from Hainan Yiling Medical Industry Development Co., Ltd	20-03-05	CI
Eagle Health Holdings Limited Announces Executive Changes	20-03-04	CI
Eagle Health Holdings Limited Announces Final Dividend for the Year Ended December 31, 2019, Payable on April 30, 2020	20-02-28	CI
Eagle Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI
Eagle Health Holdings Limited & Amka Products Ltd Enter into Collaboration Agreement	20-02-25	CI
Eagle & Zoono Announces Agreement for Distributing Zoono's Products in China	20-02-19	CI
Eagle Health Holdings Limited announced that it expects to receive AUD 5 million in funding from Acuity Capital Pty. Ltd.	20-02-16	CI
Eagle Health Awards Competitive Five-Year Contract Providing Comprehensive Occupational Medical Services to Support the National Institutes of Health	20-02-06	CI
Eagle Health Holdings Limited announced that it has received AUD 1 million in funding	19-12-04	CI
Eagle Health Holdings Limited announced that it expects to receive AUD 1 million in funding	19-11-27	CI
Eagle Health Holdings Limited Announces the Appointment of Dr. Brendan James De Kauwe as Director Effective from 18 November 2019	19-11-18	CI
Eagle Health Holding Limited Announces the Cessation of Rodney Andrew Hannington as Director Effective from 18 November 2019	19-11-18	CI
Eagle Health Holding Limited Announces the Cessation of Andrew Peter Thomson as Director	19-11-18	CI
Eagle Health Holdings Limited Announces Board Appointments	19-11-18	CI
Eagle Health Holding Limited Announces the Cessation of Liu Yuhong as Director Effective from 11 November 2019	19-11-10	CI
Eagle Health Holding Limited Announces Cessation of Chen Linxiang as Director, Effective from 11 November 2019	19-11-10	CI
Eagle Health Holdings Limited Announces the Appointment of Gang Xu as Director Effective from 11 November 2019	19-11-10	CI
Eagle Health Holdings Limited Announces Resignation of Haroon Kalla from the Board	19-10-14	CI
Eagle Health Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-28	CI
Eagle Health Holdings Limited Announces Update on the Rollout of Health and Experience Stores	19-05-12	CI

Chart Eagle Health Holdings Limited

Duration

Period

More charts

Company Profile

Eagle Health Holdings Limited is a vertically integrated nutritional product company. The Company is involved in the development, manufacture, marketing and distribution of health food and nutritional products. The Company's products include ejio series, amino acid series, teabag tea, protein powder, maca series, hemp series and dendrobium series. The Company distributes its products through a broad range of channels, including pharmacies, health food stores, trading companies, supermarkets and online channels, covering 23 provinces and autonomous regions throughout China. The Company involved in developing research and development (R&D) relationships with Australian universities and institutions. The Company has 18 patents in China, including 4 invention patents.

Sector

More about the company